These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 11310818)

  • 21. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression.
    Pyne JM; Fortney JC; Tripathi SP; Maciejewski ML; Edlund MJ; Williams DK
    Arch Gen Psychiatry; 2010 Aug; 67(8):812-21. PubMed ID: 20679589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.
    Revicki DA; Simon GE; Chan K; Katon W; Heiligenstein J
    J Fam Pract; 1998 Dec; 47(6):446-52. PubMed ID: 9866670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving depression care: barriers, solutions, and research needs.
    Von Korff M; Katon W; Unützer J; Wells K; Wagner EH
    J Fam Pract; 2001 Jun; 50(6):E1. PubMed ID: 11401751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness of integrated care for elderly depressed patients in the PRISM-E study.
    Wiley-Exley E; Domino ME; Maxwell J; Levkoff SE
    J Ment Health Policy Econ; 2009 Dec; 12(4):205-13. PubMed ID: 20195008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examining costs of chronic conditions in a Medicaid population.
    Garis RI; Farmer KC
    Manag Care; 2002 Aug; 11(8):43-50. PubMed ID: 12232928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The economic and social burden of depression.
    Sartorius N
    J Clin Psychiatry; 2001; 62 Suppl 15():8-11. PubMed ID: 11444765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The costs of depression and the cost-effectiveness of treatment].
    König HH; Luppa M; Riedel-Heller S
    Psychiatr Prax; 2010 Jul; 37(5):213-5. PubMed ID: 20597034
    [No Abstract]   [Full Text] [Related]  

  • 28. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring outcomes and costs for major depression.
    Booth BM; Zhang M; Rost KM; Clardy JA; Smith LG; Smith GR
    Psychopharmacol Bull; 1997; 33(4):653-8. PubMed ID: 9493475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generalized anxiety disorder: prevalence, burden, and cost to society.
    Wittchen HU
    Depress Anxiety; 2002; 16(4):162-71. PubMed ID: 12497648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. American health care systems and depression: the past, present, and the future.
    Hirschfeld RM
    J Clin Psychiatry; 1998; 59 Suppl 20():5-10. PubMed ID: 9881535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Depression--socioeconomic perspectives].
    Sanne B; Dahl AA; Tell GS
    Tidsskr Nor Laegeforen; 2001 Feb; 121(5):590-5. PubMed ID: 11301616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Understanding the burden of depression.
    Culpepper L
    J Clin Psychiatry; 2011 Jun; 72(6):e19. PubMed ID: 21733472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of improving primary care treatment of late-life depression.
    Katon WJ; Schoenbaum M; Fan MY; Callahan CM; Williams J; Hunkeler E; Harpole L; Zhou XH; Langston C; Unützer J
    Arch Gen Psychiatry; 2005 Dec; 62(12):1313-20. PubMed ID: 16330719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of a psychoeducational relapse prevention program for depression in primary care.
    Stant AD; TenVergert EM; Kluiter H; Conradi HJ; Smit A; Ormel J
    J Ment Health Policy Econ; 2009 Dec; 12(4):195-204. PubMed ID: 20195007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cost of depression in the workplace.
    Conti DJ; Burton WN
    Behav Healthc Tomorrow; 1995; 4(4):25-7. PubMed ID: 10172403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of systematic depression treatment among people with diabetes mellitus.
    Simon GE; Katon WJ; Lin EH; Rutter C; Manning WG; Von Korff M; Ciechanowski P; Ludman EJ; Young BA
    Arch Gen Psychiatry; 2007 Jan; 64(1):65-72. PubMed ID: 17199056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does co-morbid depressive illness magnify the impact of chronic physical illness? A population-based perspective.
    Stein MB; Cox BJ; Afifi TO; Belik SL; Sareen J
    Psychol Med; 2006 May; 36(5):587-96. PubMed ID: 16608557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case management for the treatment of patients with major depression in general practices--rationale, design and conduct of a cluster randomized controlled trial--PRoMPT (PRimary care Monitoring for depressive Patient's Trial) [ISRCTN66386086]--study protocol.
    Gensichen J; Torge M; Peitz M; Wendt-Hermainski H; Beyer M; Rosemann T; Krauth C; Raspe H; Aldenhoff JB; Gerlach FM
    BMC Public Health; 2005 Oct; 5():101. PubMed ID: 16207375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers to the diagnosis of depression in primary care.
    Docherty JP
    J Clin Psychiatry; 1997; 58 Suppl 1():5-10. PubMed ID: 9054902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.